Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 5.08 M10.78 M12.06 M11.74 M 39.66 M Research & development ———— — Operating income 8.65 M968 K-2.07 M2.24 M 9.79 M Non-Operating Income, Total 76.18 M8.99 M-1.59 M3.92 M 87.49 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 76.18 M8.99 M-1.59 M3.92 M 87.49 M Unusual income/expense ———— — Pretax income 70.42 M-4.08 M-16.44 M-6.95 M 42.96 M Equity in earnings 0-24 K48 K-1 000 23 K Taxes 3 0007 000-34 K6 000 -18 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 70.42 M-4.09 M-16.4 M-6.95 M 42.98 M Discontinued operations -495 K-965 K-1.35 M-478 K -3.29 M Net income 69.93 M-5.05 M-17.75 M-7.43 M 39.69 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 69.74 M-5.05 M-17.99 M-7.43 M 39.26 M Basic earnings per share (Basic EPS) 15.05-0.65-6.18-0.96 7.26 Diluted earnings per share (Diluted EPS) 15.05-0.65-6.18-0.96 7.26 Average basic shares outstanding 4.64 M7.74 M5.73 M7.75 M — Diluted shares outstanding 4.64 M7.74 M5.73 M7.75 M — EBITDA 9.04 M2.69 M-1.05 M3.71 M 14.39 M EBIT 8.65 M968 K-2.07 M2.24 M 9.79 M Cost of revenue -5.57 M12.12 M5.57 M3.73 M 15.85 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 394 K1.72 M1.02 M1.47 M 4.6 M